BENJAMIN RODRIGUEZ: Open Payments
NPI 1588998645 · UNION GAP, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,299 in 69 payments from 24 companies in 2025. Trend: 2023 $1,542 · 2024 $3,036 · 2025 $1,299
Food & beverage: $1,299
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $258 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $110 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $94 |
| Dexcom, Inc. | 1 | $87 |
| AstraZeneca Pharmaceuticals LP | 4 | $79 |
| Tandem Diabetes Care, Inc. | 5 | $68 |
| Daiichi Sankyo Inc. | 2 | $55 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Xeris Pharmaceuticals, Inc. | 2 | $43 |
Products named: Ozempic, Kerendia, ENTYVIO, JARDIANCE, Wegovy, Dexcom G6 Transmitter, t:slim X2 Insulin Pump with Control-IQ, INJECTAFER.
Industry payments across WA — which companies pay providers there.
